FDA ramps up routine surveillance inspections, grapples with backlog

Regulatory NewsRegulatory NewsAPIsBiologics/ biosimilars/ vaccinesBiotechnologyCompliancePharmaceuticalsRegulatory Intelligence/PolicyUnited States